Search Results - "Van Cangh, Paul"

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases by Tombal, Bertrand, Rezazadeh, Afshin, Therasse, Patrick, Van Cangh, Paul J., Vande Berg, Bruno, Lecouvet, Frédéric E.

“…BACKGROUND There is currently no technique to image quantitatively bone metastases. Here, we assessed the value of MRI of the axial skeleton (AS‐MRI) as a…”
Get full text

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) by Bolla, Michel, van Poppel, Hein, Collette, Laurence, van Cangh, Paul, Vekemans, Kris, Da Pozzo, Luigi, de Reijke, Theo M, Verbaeys, Antony, Bosset, Jean-François, van Velthoven, Roland, Maréchal, Jean-Marie, Scalliet, Pierre, Haustermans, Karin, Piérart, Marianne

“…Local failure after prostatectomy can arise in patients with cancer extending beyond the capsule. We did a randomised controlled trial to compare radical…”
Get full text

Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911 by VAN DER KWAST, Theodorus H, BOLLA, Michel, VAN POPPEL, Hein, VAN CANGH, Paul, VEKEMANS, Kris, DA POZZO, Luigi, BOSSET, Jean-Francois, KURTH, Karl H, SCHRÖDER, Fritz H, COLLETTE, Laurence

“…The randomized controlled European Organisation for Research and Treatment of Cancer (EORTC) trial 22911 studied the effect of radiotherapy after prostatectomy…”
Get full text

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? by Forget, Patrice, Tombal, Bertrand, Scholtès, Jean-Louis, Nzimbala, Jolio, Meulders, Catherine, Legrand, Catherine, Van Cangh, Paul, Cosyns, Jean-Pierre, De Kock, Marc

“…BACKGROUNDThe potential impact of intraoperative analgesics on oncological outcome after radical prostatectomy is debated. Some investigators have suggested…”
Get full text

Re: The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention by Van Cangh, Paul J

Get full text

Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy by Tombal, Bertrand, Cangh, Paul J. Van, Loric, Sylvain, Gala, Jean-Luc

“…BACKGROUND To predict poor outcome in patients with a biochemical recurrence (rising PSA) after radical prostatectomy (RP), urologists rely primarily on…”
Get full text

Prospective Randomized Evaluation of Emergency Extracorporeal Shock Wave Lithotripsy (ESWL) on the Short-Time Outcome of Symptomatic Ureteral Stones by Tombal, Bertrand, Mawlawi, Hadi, Feyaerts, Axel, Wese, Francois X., Opsomer, Reinier, Van Cangh, Paul J.

“…Here, we report the results of a randomized controlled trial (RCT) assessing the efficacy of emergency ESWL (eESWL) on the short-term outcome of symptomatic…”
Get full text

Urothelial malignancy in nephropathy due to Chinese herbs by Cosyns, J P, Jadoul, M, Squifflet, J P, Van Cangh, P J, van Ypersele de Strihou, C

Get more information

Is it always necessary to treat a ureteropelvic junction syndrome? by Van Cangh, Paul J

“…The term ureteropelvic junction (UPJ) obstruction covers different morbid entities, and the old aphorism, "A UPJ is not a UPJ" remains true. Hydronephrosis is…”
Get full text

Management of difficult kidney stones by Van Cangh, Paul, Smith, Arthur D, NG, Christopher S, Ost, Michael C, Marcovich, Robert, Wong, Michael, Joyce, Adrian D, Desai, Rahul A, Assimos, Dean G

Get more information

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis by Schubert, Maria, Joniau, Steven, Gontero, Paolo, Kneitz, Susanne, Scholz, Claus-Jürgen, Kneitz, Burkhard, Briganti, Alberto, Karnes, R. Jeffrey, Tombal, Bertrand, Walz, Jochen, Hsu, Chao-Yu, Marchioro, Giansilvio, Bader, Pia, Bangma, Chris, Frohneberg, Detlef, Graefen, Markus, Schröder, Fritz, van Cangh, Paul, van Poppel, Hein, Spahn, Martin

“…Introduction. To assess the role of adjuvant androgen deprivation therapy (ADT) in high-risk prostate cancer patients (PCa) after surgery. Materials and…”
Get full text

An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma by Gueguen, Maryse, Patard, Jean-Jacques, Gaugler, Beatrice, Brasseur, Francis, Renauld, Jean-Christophe, Van Cangh, Paul J, Boon, Thierry, Van den Eynde, Benoit J

“…By stimulating blood lymphocytes with autologous bladder carcinoma cells that had been transfected with B7-1, we obtained a panel of CTL clones which lyse…”
Get full text

Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy by Tombal, Bertrand, Querton, Michael, de Nayer, Philippe, Sauvage, Philippe, Cosyns, Jean-Pierre, Feyaerts, Axel, Opsomer, Renier, Wese, François X, Van Cangh, Paul J

“…Objectives. Despite several publications, the ability of the free/total (F/T) prostate-specific antigen (PSA) ratio to predict the pathologic extension of…”
Get full text

Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study by Joniau, Steven, Briganti, Alberto, Gontero, Paolo, Gandaglia, Giorgio, Tosco, Lorenzo, Fieuws, Steffen, Tombal, Bertrand, Marchioro, Giansilvio, Walz, Jochen, Kneitz, Burkhard, Bader, Pia, Frohneberg, Detlef, Tizzani, Alessandro, Graefen, Markus, van Cangh, Paul, Karnes, R. Jeffrey, Montorsi, Francesco, Van Poppel, Hein, Spahn, Martin

“…Abstract Background High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A clear definition of prognostic subgroups is mandatory. Objective…”
Get full text

Expression of Prostate-specific Membrane Antigen in Transitional Cell Carcinoma of the Bladder: Prognostic Value? by GALA, Jean-Luc, LORIC, Sylvain, TOMBAL, Bertrand, GUIOT, Yves, DENMEADE, Samuel Ray, GADY, Alyssa, BRASSEUR, Francis, HEUSTERSPREUTE, Michel, ESCHWEGE, Pascal, DE NAYER, Philippe, VAN CANGH, Paul

“…The expression of Prostate-specific membrane antigen (PSMA) mRNA was assessed in the normal bladder urothelium ( n = 9), transitional cell carcinoma (TCC)…”
Get full text

Intrafamilial phenotype variability in nephrogenic diabetes insipidus by Kalenga, Karine, Persu, Alexandre, Goffin, Eric, Lavenne-Pardonge, Edith, van Cangh, Paul J., Bichet, Daniel G., Devuyst, Olivier

“…X-Linked nephrogenic diabetes insipidus (NDI), which accounts for 90% of inherited cases of NDI, is caused by mutations in the AVPR2 gene that encodes the…”
Get full text

Immediate vs. delayed androgen deprivation for prostate cancer by Van Cangh, Paul J., Gala, Jean Luc, Tombal, Bertrand

“…Androgen ablation has been the standard treatment of symptomatic patients with metastatic prostate cancer for more than 50 years. Within the last 15 years, the…”
Get full text

Intermittent endocrine treatment by VAN CANGH, P. J, TOMBAL, B, GALA, J. L

“…Intermittent endocrine treatment or cyclic therapy of prostate cancer aims at prolonging survival by delaying progression to androgen independence and at…”
Get full text

Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate Cancer by Joniau, Steven, Spahn, Martin, Briganti, Alberto, Gandaglia, Giorgio, Tombal, Bertrand, Tosco, Lorenzo, Marchioro, Giansilvio, Hsu, Chao-Yu, Walz, Jochen, Kneitz, Burkhard, Bader, Pia, Frohneberg, Detlef, Tizzani, Alessandro, Graefen, Markus, van Cangh, Paul, Karnes, R. Jeffrey, Montorsi, Francesco, van Poppel, Hein, Gontero, Paolo

“…Abstract Background Pretreatment tables for the prediction of pathologic stage have been published and validated for localized prostate cancer (PCa). No such…”
Get full text

Words of wisdom. Re: The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention by Van Cangh, Paul J

Get full text